Tag: NASDAQ
Cortexyme: Addressing Unmet Needs in the Alzheimer’s Market
The stocks of Cortexyme, Inc (NASDAQ: CRTX), a clinical stage biopharmaceutical company engaged in developing novel therapeutics for Alzheimer’ disease, surged by almost 70%...
Zolmitriptan Derivatives and Novel Drug Delivery Systems Aim to treat Acute...
Migraine is a genetic predisposition to moderate-to-severe headaches caused due to stress, physiological factors such as lack of sleep, hunger and environmental triggers such...
Recent Advances in Gene Therapy and Small Molecule Inhibitors show promise...
Sjogren’s, named after its discoverer Henrik Sjögren, is the most prevalent systemic autoimmune disease that predominantly affects women. This disorder is manifested in the...
Research in Crohn’s Disease poised to change the Treatment Landscape
Crohn’s is an inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract, chronic diarrhea, abdominal cramps, rectal bleeding and constipation to name...
Emerging treatment approaches in Pruritus
Pruritus is characterized by an uncomfortable and persistent urge to scratch caused either due to a skin disorder or an underlying systemic disease such...
Emerging Therapeutics in Preeclampsia Management
Preeclampsia is a pregnancy related complication that affects over 5% to 8% of pregnancies or about 3,00,000 women in the US alone. An estimated...
TG Therapeutics – Spearheading Innovations in Lymphoma Treatment
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and autoimmune...
New Drugs show promise in curbing the Gonorrhea Menace
Gonorrhoea, caused by a bacterial pathogen N. gonorrhoea, is the second most commonly reported sexually transmitted disease in the U.S alone. The data made available...
MUSTANG BIO: SOARING TO A NEW HIGH AFTER BUBBLE BOY CURE...
Mustang Bio’s (NASDAQ: MBIO) shares rose by almost 250% after its development partner, St Jude Children’s Research Hospital in Memphis, published study results that...
Gene Therapy and Exon Skipping offer hope for patients with Duchenne...
The Muscular Dystrophy Association describes Duchenne Muscular Dystrophy (DMD) as a fatal, X-linked genetic neuromuscular disorder that leads to progressive, irreversible loss of muscle...
We are looking for talented interns to learn and help investors find valuable companies.